ÜbersichtsarbeitOpen Access
Regulatory affairs and biotechnology in Europe: III. Introduction into good regulatory practice — Validation of virus removal and inactivation
Biotherapy · 1993
DOI: 10.1007/bf01877422 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biotherapy, 1993. Verfasst von B Trijzelaar. Beteiligte Einrichtung: Strategic Biotech International, Zeist, The Netherlands. Die Arbeit wurde bisher 11-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
AnimalsBiotechnologyEuropean UnionGuidelines as TopicHumansQuality ControlReproducibility of ResultsViruses
Autor:innen und Institutionen
- Strategic Biotech International, Zeist, The Netherlands.
Zitieren
APA
Trijzelaar, B. (1993). Regulatory affairs and biotechnology in Europe: III. Introduction into good regulatory practice — Validation of virus removal and inactivation. Biotherapy. https://doi.org/10.1007/bf01877422
Vancouver
Trijzelaar B. Regulatory affairs and biotechnology in Europe: III. Introduction into good regulatory practice — Validation of virus removal and inactivation. Biotherapy. 1993. doi:10.1007/bf01877422
BibTeX
@article{Trijzelaar1993,
author = {Trijzelaar, B},
title = {Regulatory affairs and biotechnology in Europe: III. Introduction into good regulatory practice — Validation of virus removal and inactivation},
journal = {Biotherapy},
year = {1993},
doi = {10.1007/bf01877422}
}
EUVIMED